RNA-Seq – News and Features

A research article published in Science presents the first major analysis based on the Human Protein Atlas, including a detailed picture of the proteins that are linked to cancer, the number of proteins present in the bloodstream, and the targets for all approved drugs on the market.

New statistical method for RNA-seq analysis identifies, corrects for hidden structure between cells.

This appointment will allow to drive current and future developments at CiToxLAB’s European and North American sites in the area of preclinical and clinical biomarkers, which is currently experiencing strong growth.

Researchers in the United States have identified a molecular network that comprises many of the genes previously shown to contribute to autism spectrum disorders. The findings provide a map of some of the crucial protein interactions that contribute to autism and will help uncover novel candidate genes for the disease.

New collaboration between EMBL-EBI, the Wellcome Trust Sanger Institute and Fluidigm keeps research and technology on the cutting-edge of single-cell genomics.

Researchers Apply Nuanced Approach to Identify Biological Roots of Neurodevelopmental Disorders With a unique, multi-faceted approach, researchers at the Lieber Institute for Brain Development (LIBD) have quantified the effect of previously unidentified anomalies in genetic expression that determine how the human brain develops from its earliest stages.

Study examine the relationship between certain personality traits and the expression of genes.

Johns Hopkins study is largest so far of gene expression in autism brains While many different combinations of genetic traits can cause autism, brains affected by autism share a pattern of ramped-up immune responses, an analysis of data from autopsied human brains reveals.

Network of genes found to determine alcohol dependence could lead to future treatments.

New study released identifying genetic markers that signal resistance to the wheat yellow rust pathogen.